Systemic inflammation and extra-articular manifestations in rheumatoid arthritis: a cross-sectional study - Report - MDSpire

Systemic inflammation and extra-articular manifestations in rheumatoid arthritis: a cross-sectional study

  • By

  • Karlygash Sadykova

  • Gulnaz Nuskabayeva

  • Ainash Oshibayeva

  • Shakhnoza Tatykayeva

  • Elmira Iskandirova

  • Arzu Mamutova

  • Aziza Djurabekova

  • Ugilzhan Tatykayeva

  • May 15, 2026

Share

Clinical Report: Systemic Inflammation and Non-Articular Symptoms in RA

Overview

This study identifies a high prevalence of extra-articular manifestations in rheumatoid arthritis (RA) patients, linked to systemic inflammation. Key findings include significant associations between elevated inflammatory markers and the presence of these manifestations.

Background

Rheumatoid arthritis (RA) is a systemic inflammatory disorder that often presents with symptoms beyond the joints, which can lead to increased morbidity and mortality. Understanding the factors associated with extra-articular manifestations is crucial for improving patient management and outcomes.

Data Highlights

CharacteristicWith Extra-Articular ManifestationsWithout Extra-Articular Manifestations
AgeOlder (p = 0.039)
Disability Prevalence76%48% (p = 0.004)
C-reactive Protein (mg/L)20 (median)11 (median) (p = 0.015)
Erythrocyte Sedimentation Rate (mm/h)3621 (p < 0.001)
Rheumatoid Factor (IU/mL)9255.2 (p < 0.001)
Antinuclear Antibodies Index1.50.43 (p = 0.023)

Key Findings

  • Extra-articular manifestations were present in 93% of RA patients studied.
  • Patients with extra-articular manifestations were older and had higher disability rates.
  • Elevated levels of systemic inflammation markers were significantly associated with extra-articular manifestations.
  • Erythrocyte sedimentation rate (ESR) was independently correlated with extra-articular manifestations.
  • An increased white blood cell count was inversely correlated with extra-articular manifestations.

Clinical Implications

Monitoring systemic inflammation through markers like ESR is essential in managing RA, as it correlates with extra-articular manifestations. Clinicians should consider the broader implications of RA beyond joint symptoms to improve patient care and outcomes.

Conclusion

The findings underscore the importance of recognizing and addressing extra-articular manifestations in RA, driven by systemic inflammation. Further longitudinal studies are needed to clarify causality and therapeutic implications.

Related Resources & Content

  1. Clinical Rheumatology, 2023 -- Association between the systemic immune-inflammation index and risk of osteoarthritis
  2. Clinical Rheumatology, 2023 -- Early Phase Hormonal, Metabolic Peptide, and Nutrient Profiles in Rheumatoid Arthritis
  3. Clinical Rheumatology, 2023 -- Impact of Disease Perception on Persistent Pain and Fatigue in Rheumatoid Arthritis
  4. New ACR Guideline Summaries: Screen, Monitor and Treat ILD | American College of Rheumatology, 2023
  5. Clinical Rheumatology — Impact of Coexisting Hand Osteoarthritis on Pain Levels and Disease Activity in Individuals with Rheumatoid Arthritis
  6. EULAR RA Management Update 2025
  7. New ACR Guideline Summaries: Screen, Monitor and Treat ILD | American College of Rheumatology
  8. Rituximab for rheumatoid arthritis-related interstitial lung disease: A systematic review and meta-analysis | Volume 39 - Issue 2 - June 2024 | Archives of Rheumatology
  9. Subcutaneous vs intravenous abatacept in rheumatoid arthritis-interstitial lung disease. National multicentre study of 397 patients - ScienceDirect
  10. Tofacitinib Safety and Effectiveness in Canadian Patients with Rheumatoid Arthritis by Cardiovascular Risk Enrichment: Subanalysis of the CANTORAL Study | Rheumatology and Therapy | Springer Nature Link
  11. 2023 EULAR recommendations for the management of fatigue in people with inflammatory rheumatic and musculoskeletal diseases | Annals of the Rheumatic Diseases

Original Source(s)

Related Content